PM1183 plus doxorubicin shows interesting activity in small cell lung cancer

2 Views
administrator
administrator
07/14/23

Visit http://www.ecancer.org for more

Dr Calvo (START Madrid, Madrid, Spain) talks to ecancertv at ASCO 2015 about data from a Phase 1b study of the transcriptional inhibitor PM1183 in combination with doxorubicin in second line therapy in patients with small cell lung cancer (SCLC)

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next